Pamela Carroll
2018
In 2018, Pamela Carroll earned a total compensation of $488K as Senior Vice President, Immuno, Oncology at Genocea Biosciences, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $72,600 |
|---|---|
| Option Awards | $85,626 |
| Salary | $322,372 |
| Other | $7,391 |
| Total | $487,989 |
Carroll received $322.4K in salary, accounting for 66% of the total pay in 2018.
Carroll also received $72.6K in non-equity incentive plan, $85.6K in option awards and $7.4K in other compensation.
Rankings
In 2018, Pamela Carroll's compensation ranked 11,962nd out of 14,244 executives tracked by ExecPay. In other words, Carroll earned more than 16.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,962 out of 14,244 | 16th |
Division Manufacturing | 4,849 out of 5,762 | 16th |
Major group Chemicals And Allied Products | 1,835 out of 2,125 | 14th |
Industry group Drugs | 1,566 out of 1,814 | 14th |
Industry Biological Products, Except Diagnostic Substances | 303 out of 339 | 11th |
Source: SEC filing on March 29, 2019.
Carroll's colleagues
We found three more compensation records of executives who worked with Pamela Carroll at Genocea Biosciences in 2018.